Alunbrig Tablets 90mg (Brigatinib), manufactured by Takeda Pharmaceutical (YJ code: 4291069F2029, standard: 90mg 1 tablet), is a kinase inhibitor used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC) by targeting abnormal ALK and EGFR proteins to inhibit cancer cell growth.
Alunbrig Tablets 90mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →